Search Results - "Toonen, Lodewijk J. A."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies by Evers, Melvin M., Toonen, Lodewijk J. A., van Roon-Mom, Willeke M. C.

    Published in Molecular neurobiology (01-06-2014)
    “…Ataxin-3 is a ubiquitously expressed deubiqutinating enzyme with important functions in the proteasomal protein degradation pathway and regulation of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias by Buijsen, Ronald A.M., Toonen, Lodewijk J.A., Gardiner, Sarah L., van Roon-Mom, Willeke M.C.

    Published in Neurotherapeutics (01-04-2019)
    “…Autosomal dominant cerebellar ataxias (ADCAs) are a group of neurodegenerative disorders characterized by degeneration of the cerebellum and its connections…”
    Get full text
    Journal Article
  4. 4

    Huntington Disease Gene Expression Signatures in Blood Compared to Brain of YAC128 Mice as Candidates for Monitoring of Pathology by Kuijper, Elsa C., Toonen, Lodewijk J. A., Overzier, Maurice, Tsonaka, Roula, Hettne, Kristina, Roos, Marco, van Roon-Mom, Willeke M. C., Mina, Eleni

    Published in Molecular neurobiology (01-04-2022)
    “…While the genetic cause of Huntington disease (HD) is known since 1993, still no cure exists. Therapeutic development would benefit from a method to monitor…”
    Get full text
    Journal Article
  5. 5

    Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3 by Toonen, Lodewijk J. A., Schmidt, Iris, Luijsterburg, Martijn S., van Attikum, Haico, van Roon-Mom, Willeke M. C.

    Published in Scientific reports (12-10-2016)
    “…Spinocerebellar ataxia type-3 (SCA3) is a neurodegenerative disorder caused by a polyglutamine repeat expansion in the ataxin-3 protein. Cleavage of mutant…”
    Get full text
    Journal Article
  6. 6

    Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice by Toonen, Lodewijk J.A., Rigo, Frank, van Attikum, Haico, van Roon-Mom, Willeke M.C.

    Published in Molecular therapy. Nucleic acids (15-09-2017)
    “…Spinocerebellar ataxia type 3 (SCA3) is a currently incurable neurodegenerative disorder caused by a CAG triplet expansion in exon 10 of the ATXN3 gene. The…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Antisense oligonucleotides in therapy for neurodegenerative disorders by Evers, Melvin M., Toonen, Lodewijk J.A., van Roon-Mom, Willeke M.C.

    Published in Advanced drug delivery reviews (29-06-2015)
    “…Antisense oligonucleotides are synthetic single stranded strings of nucleic acids that bind to RNA and thereby alter or reduce expression of the target RNA…”
    Get full text
    Journal Article
  9. 9
  10. 10

    In vivo proof-of-concept of removal of the huntingtin caspase cleavage motif-encoding exon 12 approach in the YAC128 mouse model of Huntington’s disease by Casaca-Carreira, João, Toonen, Lodewijk J.A, Evers, Melvin M, Jahanshahi, Ali, van-Roon-Mom, Willeke M.C, Temel, Yasin

    Published in Biomedicine & pharmacotherapy (01-12-2016)
    “…Abstract Huntington’s disease (HD) is a progressive autosomal dominant disease, caused by a CAG repeat expansion in the HTT gene, resulting in an expanded…”
    Get full text
    Journal Article